BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:48 PM
 | 
Feb 08, 2010
 |  BC Extra  |  Company News

Novavax terminates vaccine deal in Spain

Novavax Inc. (NASDAQ:NVAX) terminated an agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos Rovi S.A. (Madrid:ROVI). Novavax said the decision was due to the companies' inability to agree on acceptable terms...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >